These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prognostic factors of bone and soft tissue sarcomas]. Furuse K Gan To Kagaku Ryoho; 1988 Jul; 15(7):2050-5. PubMed ID: 3293534 [TBL] [Abstract][Full Text] [Related]
3. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798 [TBL] [Abstract][Full Text] [Related]
4. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review. Dirix LY; Van Oosterom AT Semin Oncol; 1990 Apr; 17(2 Suppl 4):50-7. PubMed ID: 2185547 [TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy for soft tissue sarcoma--current concepts and review]. Umeda T; Ishii T; Hatakeyama K; Wakita H Gan To Kagaku Ryoho; 1993 Oct; 20(13):1937-44. PubMed ID: 8215466 [TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy of soft tissue sarcoma]. Shinohara N; Yokoyama K Gan To Kagaku Ryoho; 1990 Feb; 17(2):198-204. PubMed ID: 2301950 [TBL] [Abstract][Full Text] [Related]
8. Soft tissue and bone sarcomas. Santoro A; Bonadonna G Cancer Chemother Biol Response Modif; 1994; 15():620-7. PubMed ID: 7779603 [No Abstract] [Full Text] [Related]
9. [Primary chemotherapy in soft tissue sarcomas considered inoperable]. Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758 [TBL] [Abstract][Full Text] [Related]
10. [Soft tissue sarcoma: postoperative chemotherapy]. Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551 [TBL] [Abstract][Full Text] [Related]
11. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Schuetze SM; Patel S Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770 [TBL] [Abstract][Full Text] [Related]
12. Adriamycin--friend and foe. Carter SK Am J Surg Pathol; 1977 Mar; 1(1):75-7. PubMed ID: 272124 [No Abstract] [Full Text] [Related]
13. Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy. Bramwell VH Can J Surg; 1988 Nov; 31(6):390-6. PubMed ID: 3052763 [TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of sarcomas in the adult]. Rouëssé J; Tubiana-Hulin M Bull Cancer; 1988; 75(5):483-92. PubMed ID: 3165036 [TBL] [Abstract][Full Text] [Related]
15. [Evidence-based chemotherapy for patients with bone and soft part sarcoma]. Chuman H Gan To Kagaku Ryoho; 2000 Feb; 27(2):192-202. PubMed ID: 10700889 [TBL] [Abstract][Full Text] [Related]
16. The role of ifosfamide in the treatment of sarcomas. Dirix LY; Van Oosterom AT Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984 [TBL] [Abstract][Full Text] [Related]
17. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials]. Budach V Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407 [No Abstract] [Full Text] [Related]
18. [Adjuvant chemotherapy in the treatment of sarcomas]. Fayette J; Blay JY Bull Cancer; 2006 Mar; 93(3):257-61. PubMed ID: 16567312 [TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy in soft tissue sarcomas]. Tièche M; Goldhirsch A; Brunner KW Schweiz Med Wochenschr; 1980 Mar; 110(10):374-9. PubMed ID: 7394467 [TBL] [Abstract][Full Text] [Related]
20. Relationship between doxorubicin binding ability and tumor volume decrease after chemotherapy in adult malignant soft tissue tumors in the extremities. Kusuzaki K; Shinjo H; Murata H; Takeshita H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y Anticancer Res; 2000; 20(5C):3813-6. PubMed ID: 11268459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]